These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 32660514)
1. Bioinformatic analysis reveals MIR502 as a potential tumour suppressor in ovarian cancer. Li Y; Wang Q; Ning N; Tang F; Wang Y J Ovarian Res; 2020 Jul; 13(1):77. PubMed ID: 32660514 [TBL] [Abstract][Full Text] [Related]
2. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis. Li Y; Li L J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725 [TBL] [Abstract][Full Text] [Related]
3. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036 [TBL] [Abstract][Full Text] [Related]
4. Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis. Zuo L; Li X; Tan Y; Zhu H; Xiao M J Ovarian Res; 2021 Feb; 14(1):29. PubMed ID: 33563317 [TBL] [Abstract][Full Text] [Related]
5. Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis. Lei J; He ZY; Wang J; Hu M; Zhou P; Lian CL; Hua L; Wu SG; Zhou J Cancer Med; 2021 Apr; 10(8):2924-2939. PubMed ID: 33742531 [TBL] [Abstract][Full Text] [Related]
6. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay. Zhang L; Sun L; Zhang B; Chen L Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312 [TBL] [Abstract][Full Text] [Related]
7. Single-cell and transcriptomic analyses reveal the influence of diabetes on ovarian cancer. Zhao Z; Wang Q; Zhao F; Ma J; Sui X; Choe HC; Chen P; Gao X; Zhang L BMC Genomics; 2024 Jan; 25(1):1. PubMed ID: 38166541 [TBL] [Abstract][Full Text] [Related]
8. Identification of core miRNAs and regulatory pathways in breast cancer by integrated bioinformatics analysis. Feng H; Song Z Mol Omics; 2021 Apr; 17(2):277-287. PubMed ID: 33462573 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-145-5p in cancer cells and their derived exosomes may contribute to the development of ovarian cancer by targeting CT. Hang W; Feng Y; Sang Z; Yang Y; Zhu Y; Huang Q; Xi X Int J Mol Med; 2019 Jan; 43(1):256-266. PubMed ID: 30365097 [TBL] [Abstract][Full Text] [Related]
10. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway. Zhou J; Chen Q FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232 [TBL] [Abstract][Full Text] [Related]
11. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation. Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144 [TBL] [Abstract][Full Text] [Related]
12. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis. Feng H; Gu ZY; Li Q; Liu QH; Yang XY; Zhang JJ J Ovarian Res; 2019 Apr; 12(1):35. PubMed ID: 31010415 [TBL] [Abstract][Full Text] [Related]
13. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC. Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391 [TBL] [Abstract][Full Text] [Related]
14. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway. Dai C; Xie Y; Zhuang X; Yuan Z Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226 [TBL] [Abstract][Full Text] [Related]
15. Upregulated microRNA miR-21 promotes the progression of lung adenocarcinoma through inhibition of KIBRA and the Hippo signaling pathway. An Y; Zhang Q; Li X; Wang Z; Li Y; Tang X Biomed Pharmacother; 2018 Dec; 108():1845-1855. PubMed ID: 30372890 [TBL] [Abstract][Full Text] [Related]
16. Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis. Zhang K; Kong X; Feng G; Xiang W; Chen L; Yang F; Cao C; Ding Y; Chen H; Chu M; Wang P; Zhang B J Ovarian Res; 2018 Feb; 11(1):16. PubMed ID: 29482638 [TBL] [Abstract][Full Text] [Related]
17. Identification of Skt11-regulated genes in chondrocytes by integrated bioinformatics analysis. Liang S; Zhang JM; Lv ZT; Cheng P; Zhu WT; Chen AM Gene; 2018 Nov; 677():340-348. PubMed ID: 30107230 [TBL] [Abstract][Full Text] [Related]
18. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6. Xia B; Yang S; Liu T; Lou G Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927 [TBL] [Abstract][Full Text] [Related]
19. Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Gastric Carcinoma using Bioinformatics Analysis. Yang G; Zhang Y; Yang J Med Sci Monit; 2019 Nov; 25():8777-8796. PubMed ID: 31747387 [TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analysis of gene expression profile of serous ovarian carcinomas to screen key genes and pathways. Fei H; Chen S; Xu C J Ovarian Res; 2020 Jul; 13(1):82. PubMed ID: 32693821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]